Client oriented R&D services


We see ourselves as an enabling organization for our partner's research and development teams.

Accordingly, NovAliX was set up with excellence in knowledge and in execution as the driving principles.

NovAliX manages projects for clients in a truly collaborative manner with transparent interactions.

Innovative, cost effective, results oriented are the hallmarks of our corporate values.


Research Services

  • Discovery chemistry
  • Medicinal chemistry
  • Structural biology
      Download Crystal Gallery
  • Biophysical screening an d characterization
Integrated drug discovery

  • Fragment-based drug design
  • Structure-based drug design
  • Natural products-based drug design
Process R&D

  • Route design and development
  • Process optimization








Meet us
Novalix will be exhibiting at Molecular Med Tri-Con 2012 in San Francisco, USA (21th-23th February). Visit us at booth 223.

Novalix be present at Biopartnering North-America 2012 in Vancouver, Canada (26th-28th February). Contact us for the organization of a meeting.

Highlight
January 12, 2011

NovAliX SAS announced today that it has entered into a multi-target integrated drug discovery collaboration with Teijin Pharma Limited of Tokyo, Japan.
Read more...


September 13, 2011

NovAliX to collaborate with Fondation Jérôme Lejeune on Down syndrome (trisomy 21).
Read more...


August 29, 2011

NovAliX and Galapagos collaborate in osteoarthritis discovery research program.
Read more...


March 30, 2011

Graffinity Pharmaceuticals GmbH, a member of the NovAliX group of companies (www.novalix.com), announced today that it has entered into a research collaboration with Osaka, Japan based Shionogi & Co., Ltd.
Read more...


Contact Information
an image
NovAliX
BioParc, bld Sebastien Brant,
67400 Illkirch
Email: info@novalix-pharma.com

Phone: +33 (0) 368 330 200
Fax: +33 (0) 368 330 201

  Return to top